Advertisement
Screener

NeoGenomics, Inc. (NEO) Debt Securities, Available-for-sale, Realized Gain (Loss)

2.9 / 5 stars · 42/72 Roast Me

NeoGenomics, Inc. Debt Securities, Available-for-sale, Realized Gain (Loss)

NeoGenomics, Inc. (NEO) reported Debt Securities, Available-for-sale, Realized Gain (Loss) of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.

Financial Statements › Income Statement › Other Income

us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss · last filed 2026-07-28

  • NeoGenomics, Inc. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2026-06-30 was $0.00.
  • NeoGenomics, Inc. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2026-03-31 was $0.00.
  • NeoGenomics, Inc. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2025-12-31 was $0.00.
  • NeoGenomics, Inc. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2025-09-30 was $0.00.
  • NeoGenomics, Inc. debt securities, available-for-sale, realized gain (loss) for fiscal 2025 was $0.00.
  • NeoGenomics, Inc. debt securities, available-for-sale, realized gain (loss) for fiscal 2024 was $0.00.
  • NeoGenomics, Inc. debt securities, available-for-sale, realized gain (loss) for fiscal 2023 was $0.00.
  • NeoGenomics, Inc. debt securities, available-for-sale, realized gain (loss) for fiscal 2022 was $0.00.
Period endDebt Securities, Available-for-sale, Realized Gain (Loss) 3 monthDebt Securities, Available-for-sale, Realized Gain (Loss) 6 monthDebt Securities, Available-for-sale, Realized Gain (Loss) 9 monthDebt Securities, Available-for-sale, Realized Gain (Loss) 12 month
2026-06-30$0.00
10-Q · filed 2026-07-28
$0.00
10-Q · filed 2026-07-28
$0.00
derived: sum of 3 quarters · filed 2026-07-28
$0.00
derived: sum of 4 quarters · filed 2026-07-28
2026-03-31$0.00
10-Q · filed 2026-04-28
$0.00
derived: sum of 2 quarters · filed 2026-04-28
$0.00
derived: sum of 3 quarters · filed 2026-04-28
$0.00
derived: sum of 4 quarters · filed 2026-07-28
2025-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17
$0.00
derived: sum of 2 quarters · filed 2026-02-17
$0.00
derived: sum of 3 quarters · filed 2026-07-28
$0.00
10-K · filed 2026-02-17
2025-09-30$0.00
10-Q · filed 2025-10-28
$0.00
derived: sum of 2 quarters · filed 2026-07-28
$0.00
10-Q · filed 2025-10-28
$0.00
derived: sum of 4 quarters · filed 2026-07-28
2025-06-30$0.00
10-Q · filed 2026-07-28
$0.00
10-Q · filed 2026-07-28
$0.00
derived: sum of 3 quarters · filed 2026-07-28
$0.00
derived: sum of 4 quarters · filed 2026-07-28
2025-03-31$0.00
10-Q · filed 2026-04-28
$0.00
derived: sum of 2 quarters · filed 2026-04-28
$0.00
derived: sum of 3 quarters · filed 2026-04-28
$0.00
derived: sum of 4 quarters · filed 2026-04-28
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17
$0.00
derived: sum of 2 quarters · filed 2026-02-17
$0.00
derived: sum of 3 quarters · filed 2026-02-17
$0.00
10-K · filed 2026-02-17
2024-09-30$0.00
10-Q · filed 2025-10-28
$0.00
derived: sum of 2 quarters · filed 2025-10-28
$0.00
10-Q · filed 2025-10-28
$0.00
derived: sum of 4 quarters · filed 2026-02-17
2024-06-30$0.00
10-Q · filed 2025-07-29
$0.00
10-Q · filed 2025-07-29
$0.00
derived: sum of 3 quarters · filed 2026-02-17
$0.00
derived: sum of 4 quarters · filed 2026-02-17
2024-03-31$0.00
10-Q · filed 2025-04-29
$0.00
derived: sum of 2 quarters · filed 2026-02-17
$0.00
derived: sum of 3 quarters · filed 2026-02-17
$0.00
derived: sum of 4 quarters · filed 2026-02-17
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17
$0.00
derived: sum of 2 quarters · filed 2026-02-17
$0.00
derived: sum of 3 quarters · filed 2026-02-17
$0.00
10-K · filed 2026-02-17
2023-09-30$0.00
10-Q · filed 2024-11-05
$0.00
derived: sum of 2 quarters · filed 2024-11-05
$0.00
10-Q · filed 2024-11-05
$0.00
derived: sum of 4 quarters · filed 2025-02-18
2023-06-30$0.00
10-Q · filed 2024-07-30
$0.00
10-Q · filed 2024-07-30
$0.00
derived: sum of 3 quarters · filed 2025-02-18
$0.00
derived: sum of 4 quarters · filed 2025-02-18
2023-03-31$0.00
10-Q · filed 2024-04-30
$0.00
derived: sum of 2 quarters · filed 2025-02-18
$0.00
derived: sum of 3 quarters · filed 2025-02-18
$0.00
derived: sum of 4 quarters · filed 2025-02-18
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18
$0.00
derived: sum of 2 quarters · filed 2025-02-18
$0.00
derived: sum of 3 quarters · filed 2025-02-18
$0.00
10-K · filed 2025-02-18
2022-09-30$0.00
10-Q · filed 2023-11-06
$0.00
derived: sum of 2 quarters · filed 2023-11-06
$0.00
10-Q · filed 2023-11-06
2022-06-30$0.00
10-Q · filed 2023-08-08
$0.00
10-Q · filed 2023-08-08
2021-12-31$0.00
10-K · filed 2024-02-20
2021-06-30$0.00
10-Q · filed 2022-08-09
$0.00
10-Q · filed 2022-08-09
2021-03-31$0.00
10-Q · filed 2022-05-09
2020-09-30$0.00
10-Q · filed 2021-11-04
$0.00
derived: sum of 2 quarters · filed 2021-11-04
$0.00
10-Q · filed 2021-11-04
2020-06-30$0.00
10-Q · filed 2021-08-09
$0.00
10-Q · filed 2021-08-09
2020-03-31$0.00
10-Q · filed 2021-05-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
20/20 Biolabs, Inc. (AIDX)United States$0.005B